Ken Griffin Motus Gi Holdings, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$4.8 - $7.24 $3,134 - $4,727	-653 Reduced 2.09%	30,621 $9,000
Q1 2022 May 16, 2022	SELL	$6.3 - $9.86 $930,560 - $1.46 Million	-147,708 Reduced 82.53%	31,274 $11,000
Q4 2021 Feb 14, 2022	BUY	$8.58 - $15.54 $1.3 Million - $2.35 Million	151,068 Added 541.19%	178,982 $1.67 Million
Q3 2021 Nov 15, 2021	SELL	$13.8 - $20.6 $255,755 - $381,779	-18,533 Reduced 39.9%	27,914 $19,000
Q2 2021 Aug 16, 2021	BUY	$17.92 - $27.8 $611,125 - $948,063	34,103 Added 276.27%	46,447 $966,000
Q1 2021 May 17, 2021	BUY	$19.88 - $49.2 $18,528 - $45,854	932 Added 8.17%	12,344 $15,000
Q2 2020 Aug 14, 2020	SELL	$12.18 - $29.0 $199,240 - $474,382	-16,358 Reduced 58.91%	11,412 $15,000
Q1 2020 May 15, 2020	BUY	$9.94 - $54.8 $276,033 - $1.52 Million	27,770 New	27,770 $19,000

About Motus GI Holdings, Inc.

Ticker MOTS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 2,996,840
Description
Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.

More about MOTS

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.